ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Zyus Life Sciences Corporation

Zyus Life Sciences Corporation (ZYUS)

0,84
0,00
(0,00%)
Geschlossen 05 Februar 10:00PM

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
0,84
Gebot
0,81
Fragen
0,84
Volumen
-
0,00 Tagesbereich 0,00
0,70 52-Wochen-Bereich 1,19
Marktkapitalisierung
Handelsende
0,84
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
3.140
Ausgegebene Aktien
70.847.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-1,40
Gewinn pro Aktie (EPS)
-0,6
Erlöse
351k
Nettogewinn
-42,59M

Über Zyus Life Sciences Corporation

Sektor
Pharmaceutical Preparations
Branche
Oil And Gas Field Expl Svcs
Website
Hauptsitz
Toronto, Ontario, Can
Gegründet
2023
Zyus Life Sciences Corporation is listed in the Pharmaceutical Preparations sector of the TSX Venture Börse with ticker ZYUS. The last closing price for Zyus Life Sciences was $0,84. Over the last year, Zyus Life Sciences shares have traded in a share price range of $ 0,70 to $ 1,19.

Zyus Life Sciences currently has 70.847.000 shares in issue. The market capitalisation of Zyus Life Sciences is $59,51 million. Zyus Life Sciences has a price to earnings ratio (PE ratio) of -1.40.

ZYUS Neueste Nachrichten

INSERTING and REPLACING ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Insert as subheadline: NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED...

ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

ZYUS Life Sciences Corporation (“ZYUS” or the “Company”) (TSXV: ZYUS) is pleased to announce that Brent Zettl, President and CEO of ZYUS, will present and host one-on-one meetings with investors...

ZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain Management

ZYUS Receives Patent from United States Patent and Trademark Office (“USPTO”) Supporting ZYUS’ Lead Drug Candidate ZYUS Life Sciences Corporation (the “Company”) (TSX-V: ZYUS), a Canadian-based...

ZYUS Strengthens Expertise of Clinical Advisory Committee with the Appointment of Dr. Hance Clarke

Dr. Clarke Joins ZYUS’ Clinical Advisory Committee, Bringing Extensive Expertise in Healthcare and Pain Management ZYUS Life Sciences Corporation (the “Company”) (TSX-V: ZYUS), a Canadian-based...

ZYUS Strengthens Leadership Team with Appointment of Vice President of Clinical Research

Scott Livingstone brings extensive healthcare expertise and strategic leadership to ZYUS’ experienced team ZYUS Life Sciences Corporation (the “Company”) (TSX-V: ZYUS), a Canadian-based life...

ZYUS Life Sciences Corporation Announces Phase 2 Clinical Trial Evaluating Trichomylin® Softgel Capsules for Advanced Cancer Pain Management

Evaluating Efficacy, Safety, and Tolerability in Patients with Moderate to Severe Cancer-Related Pain ZYUS Life Sciences Corporation ("ZYUS" or the “Company”) (TSX-V: ZYUS), a Canadian-based life...

ZYUS Life Sciences Corporation Announces Positive Phase I Clinical Trial Results for Trichomylin® Softgels

Completion of Phase 1 and Supportive Preclinical Data Will Assist in Ongoing Phase 2 Clinical Development of ZYUS’ Lead Drug Product Candidate ZYUS Life Sciences Corporation ("ZYUS" or the...

ZYUS Life Sciences Corporation Announces New Director of Investor Relations and Capital Markets

Mr. Miller brings nearly two decades of knowledge, experience and expertise to ZYUS ZYUS Life Sciences Corporation ("ZYUS" or the “Company”) (TSX-V: ZYUS), a Canadian-based life sciences company...

ZYUS Life Sciences Corporation Obtains Health Canada Security Clearance for New Board Member Wayne Brownlee

ZYUS Life Sciences Corporation ("ZYUS" or the “Company”) (TSX-V: ZYUS), a Canadian-based life sciences company leading scientific research and global development of innovative cannabinoid-based...

ZYUS Life Sciences Strengthens Board of Directors with the Appointment of Wayne Brownlee

Mr. Brownlee brings more than 30 years of knowledge, experience and expertise to ZYUS’ Board of Directors ZYUS Life Sciences Corp. ("ZYUS" or the “Company”) (TSX-V: ZYUS), a Canadian-based life...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.011.204819277110.830.840.7814000.79714286CS
4-0.02-2.325581395350.860.940.7829300.8330371CS
120.0450.810.731400.83884393CS
26-0.06-6.666666666670.91.040.739350.85188215CS
52-0.15-15.15151515150.991.190.746580.95850409CS
156-1.66-66.42.52.50.788521.09403859CS
260-1.66-66.42.52.50.788521.09403859CS

ZYUS - Frequently Asked Questions (FAQ)

What is the current Zyus Life Sciences share price?
The current share price of Zyus Life Sciences is $ 0,84
How many Zyus Life Sciences shares are in issue?
Zyus Life Sciences has 70.847.000 shares in issue
What is the market cap of Zyus Life Sciences?
The market capitalisation of Zyus Life Sciences is CAD 59,51M
What is the 1 year trading range for Zyus Life Sciences share price?
Zyus Life Sciences has traded in the range of $ 0,70 to $ 1,19 during the past year
What is the PE ratio of Zyus Life Sciences?
The price to earnings ratio of Zyus Life Sciences is -1,4
What is the cash to sales ratio of Zyus Life Sciences?
The cash to sales ratio of Zyus Life Sciences is 168
What is the reporting currency for Zyus Life Sciences?
Zyus Life Sciences reports financial results in CAD
What is the latest annual turnover for Zyus Life Sciences?
The latest annual turnover of Zyus Life Sciences is CAD 351k
What is the latest annual profit for Zyus Life Sciences?
The latest annual profit of Zyus Life Sciences is CAD -42,59M
What is the registered address of Zyus Life Sciences?
The registered address for Zyus Life Sciences is 3400-22 ADELAIDE STREET W, TORONTO, ONTARIO, M5H 4E3
What is the Zyus Life Sciences website address?
The website address for Zyus Life Sciences is www.zyus.com
Which industry sector does Zyus Life Sciences operate in?
Zyus Life Sciences operates in the OIL AND GAS FIELD EXPL SVCS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ROCKEros Resources Corp
 0,06
(300,00%)
644,88k
NICKNickelex Resource Corporation
$ 0,01
(100,00%)
161k
TVITVI Pacific Inc
$ 0,01
(100,00%)
150k
PORPortofino Resources Inc
$ 0,01
(100,00%)
240k
FUNDKatipult Technology Corp
$ 0,01
(100,00%)
20k
DMDataMetrex AI Limited
$ 0,005
(-50,00%)
2,18M
NZPChatham Rock Phosphate Limited
$ 0,055
(-35,29%)
9k
CCDCascadero Copper Corporation
$ 0,01
(-33,33%)
4k
HBKHighbank Resources Ltd
$ 0,01
(-33,33%)
35k
SCLTSearchlight Resources Inc
$ 0,01
(-33,33%)
242k
WGOWhite Gold Corp
$ 0,20
(17,65%)
11,26M
GPUSAlset AI Ventures Inc
$ 0,115
(15,00%)
4,47M
OMIOrosur Mining Inc
$ 0,19
(65,22%)
4,45M
BRCBlackrock Silver Corp
$ 0,355
(9,23%)
2,48M
XBOTRealbotix Corp
$ 0,48
(-4,00%)
2,41M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock